“Mutations in a Gene that Impacts Immune Function Increase Susceptibility to Prostate Cancer”, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

A team of researchers led by Janet Stanford, PhD, of Fred Hutchinson Cancer Research Center, has discovered that mutations in the gene BTNL2, which encodes a protein involved in regulating T-cell proliferation and cytokine production—both of which impact immune function—increase the risk of developing prostate cancer. Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance is one of the 23 NCCN Member Institutions.